SEGMENTED INFORMATION (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
REVENUE	$ 9,770,806	$ 10,928,707
COST OF REVENUE	(8,441,308)	(9,669,678)
GROSS PROFIT	1,329,498	1,259,029
OTHER INCOME	486,036	179,283
General and administrative	(4,409,122)	(1,729,489)
FINANCE COSTS	(13,929)	(12,479)
LOSS BEFORE TAX	(2,607,517)	(303,656)
Deferred tax	17,359	(3,898)
Income tax	38,885	48,412
Tax expense	(21,526)	(52,310)
Net loss	(2,629,043)	(355,966)
GROSS PROFIT	1,329,498	1,259,029
NET LOSS	(2,629,043)	(355,966)
MRNA Scientific Malaysia [Member]
REVENUE	24,219	95,816
COST OF REVENUE	(19,851)	(51,465)
GROSS PROFIT	4,368	44,351
OTHER INCOME	19,629	8,830
General and administrative	(245,747)	(286,753)
FINANCE COSTS	(5,052)	(5,657)
LOSS BEFORE TAX	(226,802)	(239,229)
Deferred tax	12,269	1,428
Income tax	2,613	0
Tax expense	9,656	1,428
Net loss	(217,146)	(240,657)
GROSS PROFIT	4,368	44,351
NET LOSS	(217,146)	(240,657)
Chemrex [Member]
REVENUE	9,746,587	10,832,891
COST OF REVENUE	(8,421,457)	(9,618,213)
GROSS PROFIT	1,325,130	1,214,678
OTHER INCOME	466,407	170,453
General and administrative	(2,019,001)	(1,051,855)
FINANCE COSTS	(8,877)	(6,822)
LOSS BEFORE TAX	(236,341)	326,454
Deferred tax	5,090	2,470
Income tax	36,272	48,412
Tax expense	(31,182)	(50,882)
Net loss	(267,523)	275,572
GROSS PROFIT	1,325,130	1,214,678
NET LOSS	(267,523)	275,572
BGLC [Member]
REVENUE	0	0
COST OF REVENUE	0	0
GROSS PROFIT	0	0
OTHER INCOME	0	0
General and administrative	(2,144,374)	(390,881)
FINANCE COSTS	0	0
LOSS BEFORE TAX	(2,144,374)	(390,881)
Deferred tax	0	0
Income tax	0	0
Tax expense	0	0
Net loss	(2,144,374)	(390,881)
GROSS PROFIT	0	0
NET LOSS	$ (2,144,374)	$ (390,881)